Month: March 2026

Full Year 2025 Revenue Increased 16% Driven By 34% Growth in OEM Sales Announces Reduction of Expenses, Improved Cost Structure and Accelerated Path to Profitability While Providing Greater Alignment with Shareholders Targets Positive Adjusted EBITDA at $70 Million Annual Revenue Run Rate Fourth Quarter and Full Year 2025 Financial HighlightsNet sales were $13.1 million and $58.6 million. OEM net sales were $8.1 million and $36.9 million. Gross Margin was 18.2% and 26.7%. Net Loss was $(45.0) million and $(69.9) million. Adjusted EBITDA was $(3.8) million and $(11.8) million.RENO, Nev., March 16, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and battery technology and maker of Battle Born Batteries®, today announced significant...

HOUSTON, March 16, 2026 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T,” the “Company,” “we” or “us”) today reported final operational and financial results for the fourth quarter and full year 2025, including the Company’s year-end 2025 reserve report. Detailed guidance for the first quarter of 2026 and full year 2026 was also provided. The Company issued Preliminary Estimated Financial Information for the Year Ended December 31, 2025 in a Form 8-K filed with the Securities and Exchange Commission on March 9, 2026. This press release includes non-GAAP financial measures, including Adjusted Net Loss, Adjusted EBITDA, Free Cash Flow, Net Debt and PV-10, which are described and reconciled to the most comparable GAAP measures in the accompanying tables to this press release under “Non-GAAP Information.” Key highlights...

OMAHA, Neb., March 16, 2026 (GLOBE NEWSWIRE) — On March 16, 2026, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months and year ended December 31, 2025. The Partnership also announced it will host a call on Thursday, March 19th at 4:30 p.m. Eastern Time to discuss the results and business outlook. Details for accessing the call can be found below under “Earnings Webcast & Conference Call.” Financial Highlights The Partnership reported the following results as of and for the three months ended December 31, 2025:Net loss of $2.6 million or $0.17 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $2.8 million or $0.12 per BUC Total assets of $1.5 billion Total Mortgage Revenue Bond (“MRB”) and Governmental...

SOUTHLAKE, Texas, March 16, 2026 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the year and three months ended December 31, 2025. Fourth Quarter 2025 and Full Year 2025 HighlightsRental revenue of $44.3 million for the fourth quarter of 2025 represents a 16.0% year-over-year increase and a 6.8% sequential increase compared to the third quarter of 2025. Rental revenue for the full year 2025 of $164.3 million represents a 13.9% increase compared to 2024. Net income of $4.1 million, or $0.32 per diluted share, for the fourth quarter of 2025 compared to $2.9 million or $0.23 per diluted share for the fourth quarter of 2024. Net income for the full...

Lead program VMT-α-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reported at ASCO-GI 2026 VMT-α-NET study on track to achieve nearly one year of follow-up in all 46 patients in Cohort 2 by mid-2026; analysis to inform patient selection strategy ongoing Data across all dose levels in the VMT-α-NET program provide development optionality and support the build-out of a robust clinical evidence package for submission for presentation to more medical conferences and regulatory engagement in 2026 Clinical updates for all three clinical programs are expected to be submitted for presentation at medical conferences throughout 2026 Cash, cash equivalents and short-term investments of approximately $145M as of December...

Delivered full-year revenue of $981.3 million, well above upper end of guidance and the highest reported revenue in the Company’s 30-year history Full-year revenue growth of 4.5%, currency neutral growth of 3.8% Q4 revenue growth of 14.1%, currency neutral growth of 12.7% Shutterstock merger has obtained regulatory clearance without conditions in all jurisdictions except UK, where the CMA’s final report is due by June 14NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the fourth quarter and full year ended December 31, 2025. “In our 30th anniversary year we delivered record revenue, with growth across both Creative and Editorial,” said Craig Peters, Chief Executive...

Closed eSelf.ai acquisition and signed definitive agreement to acquire PathFactory, advancing the Company’s evolution into a rich, agentic digital experience platform NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) — Kaltura, Inc. (“Kaltura” or the “Company”), the rich, agentic digital experience platform, today announced financial results for the fourth quarter and full year ended December 31, 2025, as well as outlook for first quarter and full year 2026. Total revenue for the fourth quarter was $45.5 million, above the midpoint of the guidance range, with subscription revenue of $42.7 million, above the high end of the guidance range. Adjusted EBITDA for the quarter was $6.3 million, also above the high end of the guidance range, representing a new record and the Company’s tenth consecutive quarter of Adjusted EBITDA profitability. For...

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness –CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseasesAppointed industry veteran Lucinda Warren as Chief Financial and Business OfficerRaised net proceeds of $10.2M through an underwritten public offeringAnnounced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Entitled to receive upfront payments totaling $15MBOSTON, March 16, 2026 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today reported fourth...

Reports Net Loss of $49.4 Million or $1.13 per Diluted Share, and Adjusted EBITDA of ($38.3) Million BATESVILLE, Ark. , March 16, 2026 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth quarter 2025 Financial Highlights (all comparisons are with the fourth quarter of 2024)Revenues were $19.8 million, a decrease of 68%, or $41.7 million, compared to $61.5 million. Net loss was $12.0 million, or $0.27 per diluted share, down from net income of $2.8 million, or $0.06 per diluted share. Adjusted EBITDA(1) was ($8.4) million, down from $5.3 million.2025 Financial Highlights (all comparisons are with the year ended December 31, 2024)Revenues were $95.7 million,...